Sapropterin Dihydrochloride (Generic for Kuvan)

Introducing Sapropterin Dihydrochloride prepared to the Kuvan standard—a breakthrough enzyme cofactor therapy designed to enhance phenylalanine hydroxylase activity in patients with phenylketonuria. This formulation effectively lowers phenylalanine levels, thereby promoting improved metabolic control and cognitive function. Experience enhanced nutritional flexibility, reduced neurotoxicity, and superior quality of life with this advanced, targeted treatment.